Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (TNDM) designs and manufactures insulin delivery systems for people with type 1 and advanced type 2 diabetes. Its flagship product, the t:slim X2 insulin pump integrates with continuous glucose monitors and software features such as the Control‑IQ automated insulin delivery algorithm and over‑the‑air updates. The company earns revenue from pump sales, consumable supplies and software-related services and competes on ease of use, interoperability and regulatory approvals. At a market capitalisation of about $1.04 billion, Tandem is a small-cap medical devices company exposed to the growing diabetes care market. Investors should watch device adoption, regulatory milestones, reimbursement trends and partnerships. Key risks include competition from larger device makers, reimbursement uncertainty, supply-chain constraints and the potential for rapid technology change. This is general educational information and not personalised investment advice; consider your own circumstances or speak to a qualified adviser about suitability and risk.
Stock Performance Snapshot
Analyst Rating
Analysts suggest holding Tandem Diabetes Care's stock, with a target price indicating slight growth potential.
Financial Health
Tandem Diabetes Care is performing well with strong revenue and cash generation, indicating solid financial health.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring TNDM
At-Home Treatment Revolution | FDA Approval Impact
The FDA's approval of an injectable, at-home version of Eisai and Biogen's Alzheimer's drug signals a major shift in chronic disease management. This creates an investment opportunity in companies that develop advanced drug delivery systems and support at-home patient care.
Published: September 1, 2025
Explore BasketPharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Published: August 19, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Device Adoption Trends
Investors may watch increasing pump and CGM adoption as a demand driver, though uptake can vary by region and payer policies.
Software Differentiation
Control‑IQ and over‑the‑air updates can extend product value, but software and regulatory issues may affect performance and approvals.
Market & Reimbursement
Rising diabetes prevalence supports long-term demand; however, reimbursement changes and competition can influence revenue and margins.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
